StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$84.86−0.40 (-0.47%)

Close on Nov 17, 2026Market cap $21.32BP/E –Yield –

BioNTech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

BioNTech's pe ratio was 28.3× on Feb 28, 2025, against 2.2× a year earlier. Over the last 3 years it ranged from 2.2× to 31.1×, with a median of 3.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Feb 28, 202528.3×−0.4
2024Dec 31, 202428.7×+26.2
2023Dec 29, 20232.5×−1.0
2022Dec 30, 20223.5×–

More BioNTech figures

See a number that looks wrong?